The Biological Computing
About
What does The Biological Computing do?
The Biological Computing Co. (TBC) is an AI startup developing biological computing systems that utilize living neurons to create faster, cheaper, and more adaptive AI models. Their platform integrates living neurons with modern AI infrastructure to enhance foundational models and reduce compute costs. (formerly ["Biological Black Box"].)
What is The Biological Computing's revenue?
StartupHub estimates The Biological Computing's annual revenue at $3.1M (range $1.3M to $5.7M, 31% confidence), based on comparable companies in the sector.
What is The Biological Computing's valuation?
StartupHub estimates The Biological Computing's effective valuation at $99.5M (range $62.5M to $150.0M, 21% confidence), based on comparable companies in the sector.
How much funding has The Biological Computing raised?
The Biological Computing has raised a total of $25M in funding. The most recent round on record is Seed.
Where is The Biological Computing headquartered?
The Biological Computing is headquartered in San Francisco, United States.
When was The Biological Computing founded?
The Biological Computing was founded in 2023.
What industry does The Biological Computing operate in?
The Biological Computing operates in Artificial Intelligence, Biotechnology, Semiconductors, Cloud Computing, AI Infrastructure, Biotech.
What is The Biological Computing's current status?
The Biological Computing's current operating status is: Inactive.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
AI-powered platform for peptide design and discovery.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
Biotechnology startup developing next-generation cancer immunotherapies targeting shared tumor-associated antigens.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.